PineBridge Investments’s Genomic Health, Inc. GHDX Stock Holding History

PineBridge Investments’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,260	Closed	-$1.1M	–	1226
2019 Q3	$1.1M	Buy	+16,260	New	+$1.12M	0.02%	716

PineBridge Investments's GHDX Position: Q4 2019 in Review

PineBridge Investments sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 16,260 shares — an estimated $1.1M sold.

PineBridge Investments first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $1.1M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

PineBridge Investments reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
PineBridge Investments sold 16,260 Genomic Health, Inc. shares in Q4 2019, an estimated $1.1M.
PineBridge Investments first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
PineBridge Investments's Genomic Health, Inc. position peaked at $1.1M in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on PineBridge Investments's 13F filing for Q4 2019, filed 13 Feb 2020.